Affiliation:
1. Division of Clinical Pharmacology Department of Medicine Indiana University School of Medicine Indianapolis Indiana USA
2. Blueprint Medicines Cambridge Massachusetts USA
3. School of Pharmacy Purdue University West Lafayette Indiana USA
Funder
National Institute of General Medical Sciences
Indiana Clinical and Translational Sciences Institute
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience
Reference45 articles.
1. Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection
2. Long-term Safety and Efficacy of a Once-Daily Regimen of Emtricitabine, Didanosine, and Efavirenz in HIV-Infected, Therapy-Naive Children and Adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021
3. Panel on Antiretroviral Guidelines for Adults and Adolescents.Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services. . Accessed May 9 2019.
4. Bristol‐Myers Squibb Company 2017.Sustiva (efavirenz) package insert. Bristol‐Myers Squibb Company 1−38 (revised October 2017).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献